Close Menu

mergers & acquisitions

BD plans to place its GeneOhm assays on HandyLab's Jaguar system.

MDS' shareholders voted in favor of the deal at a special meeting on Tuesday.

OriGene gains products for DNA and RNA purification and multiplex assays for genotyping, microRNA profiling, and transcription factor activity analysis.

BGIP sells a range of bioscience products that are "tailored" to the Indian market, said the German firm.

Silence said that it "expects the proposed transaction to be treated as a reverse takeover … [and will be] subject to due diligence and would be conditional upon shareholder approval."

While CombiMatrix did not disclose the terms within which a recently hired investment bank will serve as its "financial and strategic advisor," such moves typically are overtures to mergers, acquisitions, or asset divestitures.

The deal caps months of speculation about Life Tech's plans for the AB Sciex mass spec business following the merger of Invitrogen and ABI last November to create the firm.

LabCorp completed its $107 million purchase of Monogram this week.

StarDrop, used to guide compound selection in drug discovery, was originally developed at Inpharmatica, which Galapagos acquired in 2006 and folded into its BioFocus DPI division.


A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.